Cardiac drug-psychotropic drug update ☆ ☆ This work was funded by the Malcolm Gibbs Foundation, Inc., New York, NY, USA (original) (raw)

Part II: Cardiac drug and psychotropic drug interactions: significance and recommendations

Anwarul karim

General Hospital Psychiatry, 1999

View PDFchevron_right

Effects of Psychotropic Drugs on Cardiovascular System

E. Timuçin Oral

Effects of Psychotropic …, 2007

View PDFchevron_right

Cardiovascular effects of psychotropic drugs

Robert Feinstein

Current problems in cardiology, 2002

View PDFchevron_right

Sudden death of cardiac origin and psychotropic drugs

Philippe Chevalier, Mohamed Chahine

View PDFchevron_right

Cardiologic side effects of psychotropic drugs

Enrico Romagnoli

Journal of Geriatric Cardiology, 2012

View PDFchevron_right

Cardiac adverse reactions associated with psychotropic drugs

François Girardin

Dialogues in Clinical Neuroscience, 2007

View PDFchevron_right

Cardiovascular Toxicity as a Result of Psychotropic Drugs

Mythily Subramaniam

Heart and Toxins, 2015

View PDFchevron_right

Update: Drug-psychotropic drug interactions

James Strain

General Hospital Psychiatry, 1997

View PDFchevron_right

Risk of arrhythmia induced by psychotropic medications: a proposal for clinical management

Poul Videbech

European Heart Journal, 2014

View PDFchevron_right

Psychotropic medications and the risk of sudden cardiac death during an acute coronary event

Matti Isohanni

European Heart Journal, 2011

View PDFchevron_right

Part II: Drug-psychotropic drug interactions and end organ dysfunction: Clinical management recommendations, selected bibliography, and updating strategies

James Strain

General Hospital Psychiatry, 1996

View PDFchevron_right

Sudden cardiac death secondary to antidepressant and antipsychotic drugs

Charles Antzelevitch

Expert Opinion on Drug Safety, 2008

View PDFchevron_right

Congenital Cardiac Defects, Council on Cardiovascular Disease in the Young, Drugs : A Statement for Healthcare Professionals From the Committee on Cardiovascular Monitoring of Children and Adolescents Receiving Psychotropic

Marcia Buck

2010

View PDFchevron_right

Psychopharmacology: Cardiac Effects of Antipsychotic Medications

mariam fayek

Psychiatric Services, 2001

View PDFchevron_right

Sudden cardiac death and antipsychotics. Part 2: Monitoring and prevention

Alex J Mitchell

Advances in Psychiatric Treatment, 2006

View PDFchevron_right

Psychotropic drug versus psychotropic drug—update

Anwarul karim

General Hospital Psychiatry, 2004

View PDFchevron_right

Cardiometabolic effects of psychotropic medications

Oluchi Abosi

Hormone molecular biology and clinical investigation, 2018

View PDFchevron_right

An Overview of Psychotropic Drug-Drug Interactions

Kelly Cozza

Psychosomatics, 2005

View PDFchevron_right

Cardiac lesions induced by neuroleptic drugs in the rabbit

Alain Tabib, Laurent Fanton

Experimental and Toxicologic Pathology, 2006

View PDFchevron_right

Antidepressant Therapies and the Cardiac Patient: A Review

David Shimm

Military Medicine, 1982

View PDFchevron_right

Review ADVERSE PSYCHIATRIC REACTIONS TO MODERN MEDICATION

NoraJane 68

View PDFchevron_right

Mechanisms Underlying the Actions of Antidepressant and Antipsychotic Drugs That Cause Sudden Cardiac Arrest

Serge Sicouri

Arrhythmia & Electrophysiology Review

View PDFchevron_right

Pharmacoepidemiological study of potential drug interactions in heart and neurological outpatients

Neetesh Jain

International Journal of Basic & Clinical Pharmacology, 2014

View PDFchevron_right

Hidden Cardiac Lesions and Psychotropic Drugs as a Possible Cause of Sudden Death in Psychiatric Patients: A Report of 14 Cases and Review of the Literature

louis-pierre jenoudet

2000

View PDFchevron_right

Exploring the use of psychotropic medication in cardiac patients with and without anxiety and its association with 1-year mortality

Pernille Cromhout

European Journal of Cardiovascular Nursing, 2021

View PDFchevron_right